Market Overview

The Biophotonics market is projected to grow from USD 64.6 Billion in 2023 to USD 146.7 Billion by 2032, exhibiting a CAGR of 10.80% during the forecast period (2023 - 2032). The development of novel photothermal tomography (PAT) systems, the rising elderly population, the expanding application of biophotonics in cell and tissue diagnostics, and the rise of nanotechnology in biophotonics are the main market factors driving market expansion.

Market Dynamics

The current analytical techniques used by the biophotonics sector can only collect data from datasets' surface, which implies that important information that these datasets may be able to supply is lost. In order to completely evaluate huge datasets and deliver more helpful information, big data and machine learning technologies have been merged. The use of biophotonics is accelerating because machine learning may be able to perform comprehensive analysis and extract important information. increasing sales in the Biophotonics market as a result. Big data technologies and machine learning are being employed more and more in biomedical and healthcare research as a result of the enormous volumes of clinical and biological data that are being generated and gathered at an unparalleled rate and volume.

However, due to the intricacy of the technology, the market's growth is constrained by the high cost of devices based on biophotonics. However, it is projected that technical advancement will lead to a decrease in the price of biophotonics equipment in the next years.

Market Segmentation

Based on the application, the market segments of biophotonics is divided into Microscopy, See-through Imaging, Light Therapy, Biosensors, Inside Imaging, and Surface Imaging (endoscopy) and Others. The category for see-through imaging, which had a market value of roughly USD 21.9 billion and a market share of 42.4% in 2022, had the largest share of the market.

In-vivo and In-vitro applications make up the two market segments for biophotonics.  The in-vivo segment dominated the market. Optical breast cancer imaging, functional brain imaging, endoscopy, exercise medicine, and tracking the effectiveness of photodynamic therapy and neoadjuvant chemotherapy are just a few of the medicinal uses for in vivo biophotonics.

Based on the end use, the biophotonics market segmentation is divided into Medical Therapeutics, Medical Diagnostics, and Others.  The medical diagnostics industry held the largest market share in 2023 because to its wide use by a variety of end users, including healthcare providers, instrument manufacturers, medical institutes, and research labs.

Regional Analysis

The North American biophotonics market is now in the lead and is expected to remain there for a few more years. The growth of nanotechnology has had a tremendous impact on the U.S. biophotonics business. The biophotonics market in the United States held the largest market share in North America, while the market in Canada grew at the fastest rate.

The European biophotonics market is being propelled to take a leading position in the global biophotonics market by the demand for better healthcare services, rising healthcare costs, and an aging population. The area has reliable medical facilities as well as a sizable number of important biophotonics industry companies. It is anticipated that the medical diagnostics sector would dominate the biophotonics market in Europe due to the rising demand for sophisticated and non-invasive diagnostic equipment. The rising use of microscopy techniques in medical research and diagnostics is anticipated to lead to a significant expansion of the microscopy application industry in the region. In addition, the German biophotonics market had the largest market share while the U.K. biophotonics market expanded the fastest in Europe.

The biophotonics market in Asia Pacific is predicted to grow at the fastest rate during the forecast period. The rapid industrialization that is occurring in nations like South Korea, China, Malaysia, and India is to blame for this. As a consequence of intensifying government initiatives, improvements made to healthcare facilities, and increased investment by the major industry players, the biophotonics market in Asia Pacific is anticipated to grow over the next years. China had the largest market share and India's market for biophotonics expanded at the fastest rate in the Asia-Pacific region.

Competitive Research

The Global biophotonics market players include Oxford Instruments, Olympus Corporation, Lumenis Be Ltd., IDEX, Zenalux Biomedical, Inc., Glenbrook Technologies, Photonics Media, and Thermo Fisher Scientific Inc. are significant market participants in the biophotonics industry.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com